What is the treatment for a fungal skin infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Fungal Skin Infections

For most superficial fungal skin infections, topical antifungal agents are the first-line treatment, with systemic therapy reserved for extensive disease, nail infections, scalp infections, or treatment failures. 1

Treatment by Infection Type

Candidal Skin Infections (Intertrigo)

  • Topical azoles (clotrimazole, miconazole) or polyenes (nystatin) are effective first-line treatments for candidal skin infections, particularly in skin folds of obese and diabetic patients 2, 1
  • Keeping the infected area dry is essential for treatment success—failure to do this is a common pitfall that undermines therapy 2, 1
  • Treatment duration typically ranges from 1-2 weeks with topical agents 3

Candidal Paronychia

  • Drainage is the most critical intervention, followed by topical antifungal therapy 2, 1

Dermatophyte Infections (Tinea Corporis, Tinea Cruris, Tinea Pedis)

Topical therapy:

  • Fungicidal agents (allylamines: terbinafine, naftifine, butenafine) are preferred over fungistatic agents (azoles) because they kill fungi rather than just inhibiting growth 3
  • Allylamines achieve high cure rates with treatment as short as once daily for 1 week 3
  • This is clinically important because patients often stop treatment when skin appears healed (typically after 1 week)—fungi recur more frequently with fungistatic drugs if treatment is stopped early 3
  • Azoles (miconazole, clotrimazole, ketoconazole) remain effective alternatives, particularly for mixed infections or yeast involvement 3, 4

Systemic therapy (for extensive or resistant cases):

  • Terbinafine 250 mg daily for 1-2 weeks 5
  • Itraconazole 100 mg daily for 2 weeks or 200 mg daily for 7 days 5
  • Fluconazole 50-100 mg daily or 150 mg once weekly for 2-3 weeks 5

Tinea Capitis (Scalp Ringworm)

  • Oral therapy is required—topical agents alone are ineffective 2, 1
  • Griseofulvin remains the only licensed treatment for children in the UK: 20 mg/kg daily for 6-8 weeks, taken with fatty food to improve absorption 2
  • Treatment should ideally await fungal confirmation, but in high-risk populations with typical features (scaling, lymphadenopathy, alopecia) or kerion, start therapy immediately 2
  • Add topical antifungal shampoos (ketoconazole 2%, selenium sulfide 1%, or povidone-iodine) to reduce spore transmission, though these alone are insufficient for cure 2

Onychomycosis (Nail Infections)

  • Topical agents are ineffective for nail infections—oral therapy is required 1
  • For dermatophyte nail infections: terbinafine or itraconazole are preferred over griseofulvin 1
  • For Candida onychomycosis: azoles are preferred because terbinafine has limited activity against yeasts 1
  • Treatment duration is prolonged (typically 6-12 weeks or longer) due to slow nail growth 4

Pityriasis Versicolor

Topical therapy (first-line):

  • Topical azoles or selenium sulfide for localized disease 4

Systemic therapy (for extensive disease):

  • Itraconazole 200 mg daily for 5-7 days 5, 4
  • Fluconazole 400 mg as a single dose 5, 4
  • Note: Terbinafine is ineffective for pityriasis versicolor 5

Critical Pitfalls to Avoid

  • Do not use topical therapy alone for tinea capitis or onychomycosis—these require systemic treatment 2, 1
  • Do not prescribe terbinafine for yeast infections (Candida or pityriasis versicolor)—it lacks adequate activity against yeasts 1, 5
  • Ensure the infected area stays dry, especially for intertrigo—moisture undermines treatment efficacy 2, 1
  • Be aware of emerging terbinafine resistance in Trichophyton mentagrophytes ITS genotype VIII (T. indotineae)—if treatment fails, consider resistance testing and switch to itraconazole 4
  • Patients often stop treatment when skin appears healed (typically after 1 week)—this is why fungicidal agents (allylamines) are preferred over fungistatic agents (azoles) for dermatophyte infections 3

Special Considerations

  • For widespread infections, hair follicle involvement, or treatment failures, systemic therapy is necessary 3
  • Cost considerations may influence choice, especially for large body surface areas—generic topical agents are generally effective regardless of mechanism 3
  • Always combine oral antifungal treatment with topical therapy for optimal outcomes 4

References

Guideline

Treatment for Skin Fungal Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Topical therapy for fungal infections.

American journal of clinical dermatology, 2004

Research

[Dermatomycoses: topical and systemic antifungal treatment].

Dermatologie (Heidelberg, Germany), 2024

Research

Oral therapy of common superficial fungal infections of the skin.

Journal of the American Academy of Dermatology, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.